• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重流感:危重症患者概述。

Severe influenza: overview in critically ill patients.

机构信息

Infectious Diseases Department, Fondazione I.R.C.C.S Policlinico San Matteo Pavia, Italy.

Infectious Diseases Department, São João University Hospital Center.

出版信息

Curr Opin Crit Care. 2019 Oct;25(5):449-457. doi: 10.1097/MCC.0000000000000638.

DOI:10.1097/MCC.0000000000000638
PMID:31313681
Abstract

PURPOSE OF REVIEW

Overview of influenza infection, focusing on outcome and complications in critically ill patients. We also discuss relevant elements in immunopathogenesis and their role as predictors of severity.

RECENT FINDINGS

Pandemic influenza A (H1N1) virus circulates seasonally and remains the predominant subtype among intensive care patients. Mortality in acute respiratory failure (ARF) is around 20%, independent of influenza subtypes. During severe infection, the imbalance between pro-inflammatory and anti-inflammatory molecules, such as Th1 and Th17 cytokines, is associated with complicated infections and mortality. Primary viral pneumonia presents in more than 70% of ICU influenza patients and more than 50% develop acute respiratory distress syndrome. Bacterial secondary infection occurs in 20% of severe cases and Streptococcus pneumoniae and Staphylococcus aureus remain the prevalent pathogens. Myocarditis and late-onset cardiovascular complications are associated with mortality. Antiviral therapy within 48 h after onset, avoidance of corticosteroids and rescue therapies for ARF or myocarditis, such as extracorporeal membrane oxygenation, improve survival.

SUMMARY

The present review summarizes current knowledge on pathogenesis and clinical manifestations of severe influenza. Immunological dysfunction during viral infection correlates with severity and mortality among ICU patients. A theranostics strategy should be implemented to improve outcomes.

摘要

目的综述

概述流感感染,重点关注危重症患者的结局和并发症。我们还讨论了免疫发病机制中的相关因素及其作为严重程度预测因子的作用。

最近的发现

季节性流行的甲型流感(H1N1)病毒仍然是重症监护患者中主要的亚型。急性呼吸衰竭(ARF)的死亡率约为 20%,与流感亚型无关。在严重感染期间,促炎和抗炎分子(如 Th1 和 Th17 细胞因子)之间的失衡与复杂感染和死亡率相关。原发性病毒性肺炎在超过 70%的 ICU 流感患者中出现,超过 50%的患者发展为急性呼吸窘迫综合征。20%的重症患者发生继发性细菌感染,肺炎链球菌和金黄色葡萄球菌仍然是主要病原体。心肌炎和迟发性心血管并发症与死亡率相关。发病后 48 小时内使用抗病毒治疗、避免使用皮质类固醇以及对 ARF 或心肌炎进行挽救性治疗(如体外膜氧合)可提高生存率。

总结

本综述总结了严重流感的发病机制和临床表现的最新知识。病毒感染期间的免疫功能障碍与 ICU 患者的严重程度和死亡率相关。应该实施一种治疗策略来改善结局。

相似文献

1
Severe influenza: overview in critically ill patients.严重流感:危重症患者概述。
Curr Opin Crit Care. 2019 Oct;25(5):449-457. doi: 10.1097/MCC.0000000000000638.
2
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].[西班牙重症与危重症医学及冠心病监护病房学会(SEMICYUC)传染病工作组(GTEI)以及西班牙传染病与临床微生物学会(SEIMC)危重症患者感染研究组(GEIPC)关于入住重症监护病房的重症成年甲型H1N1流感患者诊断和治疗的建议]
Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13.
3
Extracorporeal membrane oxygenation for 2009 influenza A (H1N1)-associated acute respiratory distress syndrome.体外膜肺氧合治疗 2009 年甲型 H1N1 流感相关性急性呼吸窘迫综合征。
Semin Respir Crit Care Med. 2011 Apr;32(2):188-94. doi: 10.1055/s-0031-1275531. Epub 2011 Apr 19.
4
2009 pandemic influenza A (H1N1) in critically ill children in Cincinnati, Ohio.2009 年俄亥俄州辛辛那提市危重症儿童中的甲型流感 A(H1N1)疫情。
Pediatr Crit Care Med. 2012 May;13(3):e140-4. doi: 10.1097/PCC.0b013e318228845f.
5
Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.甲型 H1N1 流感大流行期间危重症患者血清甘露糖结合凝集素水平与重症结局的前瞻性观察性研究。
Lung. 2018 Feb;196(1):65-72. doi: 10.1007/s00408-017-0067-5. Epub 2017 Dec 22.
6
Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey.土耳其儿科重症监护病房中患有大流行性流感(H1N1)的危重病儿童。
Pediatr Crit Care Med. 2012 Jan;13(1):e11-7. doi: 10.1097/PCC.0b013e31820aba37.
7
[The use of extracorporeal membrane oxygenation (ECMO) in the treatment of acute respiratory distress syndrome due to pandemic influenza].[体外膜肺氧合(ECMO)在治疗大流行性流感所致急性呼吸窘迫综合征中的应用]
Kardiol Pol. 2011;69(4):416-20.
8
[Pneumonia and acute respiratory distress syndrome due to pandemic influenza H1N1 2009].2009年甲型H1N1流感大流行所致肺炎及急性呼吸窘迫综合征
Nihon Rinsho. 2010 Sep;68(9):1666-70.
9
Low-tidal volume mechanical ventilation in patients with acute respiratory distress syndrome caused by pandemic influenza A/H1N1 infection.低潮气量机械通气在甲型 H1N1 流感病毒导致的急性呼吸窘迫综合征患者中的应用。
J Crit Care. 2013 Aug;28(4):358-64. doi: 10.1016/j.jcrc.2013.03.001. Epub 2013 Apr 17.
10
Clinical course of ICU patients with severe pandemic 2009 influenza A (H1N1) pneumonia: single center experience with proning and pressure release ventilation.重症监护病房严重大流行性 2009 流感 A(H1N1)肺炎患者的临床病程:俯卧位和压力释放通气的单中心经验。
J Intensive Care Med. 2012 May-Jun;27(3):184-90. doi: 10.1177/0885066610396168. Epub 2011 May 18.

引用本文的文献

1
AI-driven early detection of severe influenza in Jiangsu, China: a deep learning model validated through the design of multi-center clinical trials and prospective real-world deployment.中国江苏基于人工智能的严重流感早期检测:通过多中心临床试验设计和前瞻性实际应用验证的深度学习模型
Front Public Health. 2025 Aug 18;13:1610244. doi: 10.3389/fpubh.2025.1610244. eCollection 2025.
2
Gasdermin E is Dispensable for H1N1 Influenza Virus Pathogenesis in Mice.Gasdermin E对小鼠甲型流感病毒发病机制无必需性。
bioRxiv. 2025 Jul 29:2025.07.29.667514. doi: 10.1101/2025.07.29.667514.
3
Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome.
纳米颗粒驱动的黏膜免疫调节及其与微生物群的相互作用
J Microbiol Biotechnol. 2025 Jun 12;35:e2404033. doi: 10.4014/jmb.2504.04033.
4
Pharmacodynamic Effect of Different Dosage Regimes of Oseltamivir in Severe Influenza Patients Requiring Mechanical Ventilation: A Multicentre Randomised Controlled Trial.奥司他韦不同给药方案对需要机械通气的重症流感患者的药效学影响:一项多中心随机对照试验
Influenza Other Respir Viruses. 2025 May;19(5):e70109. doi: 10.1111/irv.70109.
5
Antiviral activity of silver nanoparticles against H1N1 influenza virus.银纳米颗粒对H1N1流感病毒的抗病毒活性。
BMC Res Notes. 2025 Feb 18;18(1):75. doi: 10.1186/s13104-025-07143-0.
6
Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults.流感与衰老:老年人的临床表现、并发症及治疗方法
Drugs Aging. 2025 Jan;42(1):39-55. doi: 10.1007/s40266-024-01169-y. Epub 2025 Jan 7.
7
Microbial signatures predictive of short-term prognosis in severe pneumonia.预测重症肺炎短期预后的微生物特征。
Front Cell Infect Microbiol. 2024 Aug 2;14:1397717. doi: 10.3389/fcimb.2024.1397717. eCollection 2024.
8
Mathematical Modeling Suggests That Monocyte Activity May Drive Sex Disparities during Influenza Infection.数学模型表明,单核细胞活性可能导致流感感染期间的性别差异。
Viruses. 2024 May 24;16(6):837. doi: 10.3390/v16060837.
9
Infectious factors in myocarditis: a comprehensive review of common and rare pathogens.心肌炎中的感染因素:常见和罕见病原体的综合综述
Egypt Heart J. 2024 May 24;76(1):64. doi: 10.1186/s43044-024-00493-3.
10
Latest developments in early diagnosis and specific treatment of severe influenza infection.重症流感感染早期诊断与特异性治疗的最新进展
J Intensive Med. 2023 Dec 19;4(2):160-174. doi: 10.1016/j.jointm.2023.09.006. eCollection 2024 Apr.